- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 226 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 213 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| 14.04. | Exousia Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 07.04. | Exousia Pro, Inc.: NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test | 1 | GlobeNewswire (USA) | ||
| 17.03. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 500 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 131 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 10.02. | Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition | 1 | GlobeNewswire (USA) | ||
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 473 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 423 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 491 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 359 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 507 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 657 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 479 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 519 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 502 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 404 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 557 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 585 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 236,70 | -5,24 % | Sartorius-CEO im AKTIONÄR-Interview: "KI wird die Life-Science-Branche grundlegend verändern" | Der Laborausrüster Sartorius hat sich zuletzt neue Wachstumsziele auf die Fahnen geschrieben. Im Interview mit dem AKTIONÄR verrät CEO Michael Grosse, welche Auswirkungen die derzeitigen geopolitischen... ► Artikel lesen | |
| SERVE ROBOTICS | 7,745 | -0,06 % | Serve Robotics Inc.: Serve Robotics Continues Expansion Beyond Food Delivery, Launches Autonomous Laundry Vertical with NoScrubs | ||
| UNUSUAL MACHINES | 26,380 | +0,04 % | Unusual Machines, Inc.: Unusual Machines Promotes Trish Ellis to Vice President of Human Resources | Promotion reflects continued investment in organizational infrastructure and operational scale ORLANDO, FL / ACCESS Newswire / June 1, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), a leading manufacturer... ► Artikel lesen | |
| LIGHTWAVE LOGIC | 10,140 | 0,00 % | Aktien New York Ausblick: Rekordrally pausiert - Halbleiter-Hausse geht weiter | NEW YORK (dpa-AFX) - Die US-Börsen dürften nach der jüngsten Rekordjagd am Dienstag erst einmal eine Pause einlegen. Dank der anhaltenden Halbleiter-Hausse sowie optimistischer Aussagen von US-Präsident... ► Artikel lesen | |
| DRONESHIELD | 1,782 | +0,28 % | US Auftrag treibt Drohnenabwehr Aktie: DroneShield Aktie steigt Neuer Millionenvertrag mit US Taskforce | Die DroneShield Aktie legt zu. Der australische Spezialist für Drohnenabwehr hat in den USA einen weiteren bedeutenden Auftrag erhalten. Der Vertrag mit einer US Taskforce hat ein mögliches Volumen... ► Artikel lesen | |
| 2G ENERGY | 67,75 | -1,09 % | KI-Boom braucht mehr Strom: Cameco, Standard Uranium und 2G Energy profitieren! | Die Investitionsbereitschaft der großen Technologiekonzerne Amazon, Microsoft, Alphabet, Meta und Oracle in KI-Rechenzentren ist ungebrochen. Trotz erster Negativ-News (Verschuldung, Cashflow-Einbruch)... ► Artikel lesen | |
| AIRJOULE TECHNOLOGIES | 4,860 | -0,21 % | Why Did AirJoule Technologies Stock Give Back Most of Its Gain This Week? | ||
| ITURAN LOCATION AND CONTROL | 63,05 | 0,00 % | Ituran Location and Control Ltd.: Ituran Presents First Quarter 2026 Results | Revenue growth of 19% and subscription revenue up 21% year-over-year;
EBITDA grows 15% to $26.7 million;
AZUR, Israel, May 26, 2026 /PRNewswire/ -- Ituran Location... ► Artikel lesen | |
| PVA TEPLA | 40,720 | -4,19 % | EQS-PVR: PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: PVA TePla AG
PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| SIMPPLE | 3,820 | +1,06 % | SIMPPLE LTD. - 20-F, Annual and transition report of foreign private issuers | ||
| GPGI | 11,880 | 0,00 % | GPGI, Inc. - 8-K, Current Report | ||
| EVOLV TECHNOLOGIES | 5,900 | -0,17 % | Evolv Technologies Reports Q1 2026 Results: Full Earnings Call Transcript | ||
| AXON ENTERPRISE | 422,20 | +0,02 % | Opening Bell: Bitcoin, Strategy, Broadcom, Marvell, Micron, Axon Enterprise, Moderna, Lululemon | Die US-Börsen haben am Donnerstag eine zweigeteilte Entwicklung gezeigt. Der Dow Jones eröffnete mit klaren Gewinnen, baute diese im Verlauf deutlich aus und schloss 1,73 Prozent fester. Der Nasdaq... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 167,00 | 0,00 % | EQS-HV: Pfeiffer Vacuum Technology AG: Bekanntmachung der Einberufung zur Hauptversammlung am 10.07.2026 in Asslar mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Pfeiffer Vacuum Technology AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
Pfeiffer Vacuum Technology AG: Bekanntmachung der Einberufung zur Hauptversammlung... ► Artikel lesen | |
| KRATOS DEFENSE | 50,79 | 0,00 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.